Pyridostigmine and Amifampridine for Myasthenia Gravis

Clinical trial NCT05919407 · UNKNOWN

Trial details

NCT number: NCT05919407
Sponsor: Leiden University Medical Center
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Myasthenia Gravis

Start date: 2023-03-22
Primary completion: 2024-09-22
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.